DK0771566T3 - Stabilisering af kolloidale systemer ved dannelsen af ioniske lipidpolysaccharidkomplekser - Google Patents
Stabilisering af kolloidale systemer ved dannelsen af ioniske lipidpolysaccharidkomplekserInfo
- Publication number
- DK0771566T3 DK0771566T3 DK96914215T DK96914215T DK0771566T3 DK 0771566 T3 DK0771566 T3 DK 0771566T3 DK 96914215 T DK96914215 T DK 96914215T DK 96914215 T DK96914215 T DK 96914215T DK 0771566 T3 DK0771566 T3 DK 0771566T3
- Authority
- DK
- Denmark
- Prior art keywords
- formation
- colloidal systems
- stabilization
- systems
- useful
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5192—Processes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/70—Nanostructure
- Y10S977/788—Of specified organic or carbon-based composition
- Y10S977/797—Lipid particle
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/70—Nanostructure
- Y10S977/788—Of specified organic or carbon-based composition
- Y10S977/797—Lipid particle
- Y10S977/798—Lipid particle having internalized material
- Y10S977/799—Containing biological material
- Y10S977/801—Drug
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/906—Drug delivery
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/906—Drug delivery
- Y10S977/907—Liposome
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/915—Therapeutic or pharmaceutical composition
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/926—Topical chemical, e.g. cosmetic or sunscreen
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES09501035A ES2093562B1 (es) | 1995-05-26 | 1995-05-26 | Estabilizacion de sistemas coloidales mediante formacion de complejos ionicos lipido-polisacarido. |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0771566T3 true DK0771566T3 (da) | 2006-10-23 |
Family
ID=8290513
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK96914215T DK0771566T3 (da) | 1995-05-26 | 1996-05-24 | Stabilisering af kolloidale systemer ved dannelsen af ioniske lipidpolysaccharidkomplekser |
Country Status (9)
Country | Link |
---|---|
US (1) | US5843509A (de) |
EP (1) | EP0771566B1 (de) |
AT (1) | ATE330636T1 (de) |
CA (1) | CA2195881C (de) |
DE (1) | DE69634927T2 (de) |
DK (1) | DK0771566T3 (de) |
ES (1) | ES2093562B1 (de) |
PT (1) | PT771566E (de) |
WO (1) | WO1996037232A1 (de) |
Families Citing this family (79)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5766629A (en) | 1995-08-25 | 1998-06-16 | Sangstat Medical Corporation | Oral cyclosporin formulations |
US6416778B1 (en) | 1997-01-24 | 2002-07-09 | Femmepharma | Pharmaceutical preparations and methods for their regional administration |
US5993856A (en) * | 1997-01-24 | 1999-11-30 | Femmepharma | Pharmaceutical preparations and methods for their administration |
FR2760641B1 (fr) * | 1997-03-13 | 2000-08-18 | Oreal | Emulsion huile-dans-eau stable, son procede de fabrication et son utilisation dans les domaines cosmetique et dermatologique |
DE19733625A1 (de) * | 1997-07-28 | 1999-02-04 | Lancaster Group Gmbh | Dekorative kosmetische O/W-Emulsion |
KR19990058599A (ko) * | 1997-12-30 | 1999-07-15 | 손경식 | 이중 캡슐을 함유하는 화장료 조성물 |
DE19826503A1 (de) * | 1998-06-13 | 1999-12-16 | Beiersdorf Ag | Kosmetische und dermatologische Zubereitungen mit einem Gehalt an Chitosan und Phospholipiden |
AU1275401A (en) * | 1999-10-29 | 2001-05-14 | Hunza Di Maria Carmela Marazzita S.A.S. | Fibrous-liponutritional complexes and compositions containing them |
FR2801811B1 (fr) * | 1999-12-06 | 2002-05-03 | Gerard Habar | Procede de fabrication de microcapsules portant des charges cationiques |
AU2001246459A1 (en) * | 2000-02-23 | 2001-09-03 | Henkel Kommanditgesellschaft Auf Aktien | Microcapsules and/or nanocapsules |
US6761901B1 (en) | 2000-05-02 | 2004-07-13 | Enzrel Inc. | Liposome drug delivery |
US6455073B1 (en) | 2000-07-10 | 2002-09-24 | Enzrel, Inc. | Covalent microparticle-drug conjugates for biological targeting |
US6689760B1 (en) | 2000-07-10 | 2004-02-10 | Enzrel Inc. | Anti-mycobacterial compositions |
AU2001296480A1 (en) | 2000-10-02 | 2002-04-15 | Kimberly-Clark Worldwide, Inc. | Recording medium with nanoparticles and methods of making the same |
US20030133972A1 (en) * | 2000-10-11 | 2003-07-17 | Targesome, Inc. | Targeted multivalent macromolecules |
US20030129223A1 (en) * | 2000-10-11 | 2003-07-10 | Targesome, Inc. | Targeted multivalent macromolecules |
WO2002072011A2 (en) * | 2001-03-08 | 2002-09-19 | Targesome, Inc. | Stabilized therapeutic and imaging agents |
US6673263B2 (en) | 2001-07-26 | 2004-01-06 | Ppg Industries Ohio, Inc. | Compositions incorporating chitosan for paint detackification |
US20040000329A1 (en) * | 2001-07-26 | 2004-01-01 | Albu Michael L. | Compositions and methods for paint overspray removal processes |
EP1443905A4 (de) * | 2001-10-03 | 2010-06-23 | Univ Johns Hopkins | Zusammensetzungen für die orale gentherapie und verwendungsverfahren dafür |
PL370889A1 (en) * | 2001-12-20 | 2005-05-30 | Femmepharma, Inc. | Vaginal delivery of drugs |
WO2003059288A2 (en) * | 2002-01-09 | 2003-07-24 | Enzrel, Inc. | Liposome drug delivery of polycyclic, aromatic, antioxidant or anti-inflammatory compounds |
US20030176310A1 (en) * | 2002-03-15 | 2003-09-18 | Huang Robert Y.M. | Chitosan/anionic surfactant complex membrane |
ES2197836B1 (es) * | 2002-06-28 | 2005-05-01 | Consejo Sup. Investig. Cientificas | Procedimiento para la preparacion de nano-emulsiones de tipo agua en aceite (w/o) por metodos de emulsificacion de condensacion. |
US6780896B2 (en) * | 2002-12-20 | 2004-08-24 | Kimberly-Clark Worldwide, Inc. | Stabilized photoinitiators and applications thereof |
US8409618B2 (en) | 2002-12-20 | 2013-04-02 | Kimberly-Clark Worldwide, Inc. | Odor-reducing quinone compounds |
US7666410B2 (en) | 2002-12-20 | 2010-02-23 | Kimberly-Clark Worldwide, Inc. | Delivery system for functional compounds |
US9173836B2 (en) | 2003-01-02 | 2015-11-03 | FemmeParma Holding Company, Inc. | Pharmaceutical preparations for treatments of diseases and disorders of the breast |
EP1578421A4 (de) * | 2003-01-02 | 2009-04-22 | Femmepharma Holding Co Inc | Pharmazeutische präparate für diebehandlung von erkrankungen und pathologischen zuständen der brust |
WO2005018773A1 (en) * | 2003-08-20 | 2005-03-03 | Merck Patent Gmbh | Methods for extraction and concentration of hydrophilic compounds from hydrophobic liquid matrices |
US7794737B2 (en) | 2003-10-16 | 2010-09-14 | Kimberly-Clark Worldwide, Inc. | Odor absorbing extrudates |
US7678367B2 (en) | 2003-10-16 | 2010-03-16 | Kimberly-Clark Worldwide, Inc. | Method for reducing odor using metal-modified particles |
US7879350B2 (en) | 2003-10-16 | 2011-02-01 | Kimberly-Clark Worldwide, Inc. | Method for reducing odor using colloidal nanoparticles |
US7837663B2 (en) | 2003-10-16 | 2010-11-23 | Kimberly-Clark Worldwide, Inc. | Odor controlling article including a visual indicating device for monitoring odor absorption |
US7488520B2 (en) | 2003-10-16 | 2009-02-10 | Kimberly-Clark Worldwide, Inc. | High surface area material blends for odor reduction, articles utilizing such blends and methods of using same |
US7413550B2 (en) | 2003-10-16 | 2008-08-19 | Kimberly-Clark Worldwide, Inc. | Visual indicating device for bad breath |
US7754197B2 (en) | 2003-10-16 | 2010-07-13 | Kimberly-Clark Worldwide, Inc. | Method for reducing odor using coordinated polydentate compounds |
KR20060097020A (ko) * | 2003-10-31 | 2006-09-13 | 테바 파마슈티컬 인더스트리즈 리미티드 | 약물 전달용 나노입자 |
KR100638041B1 (ko) * | 2003-12-24 | 2006-10-23 | 주식회사 삼양사 | 수용성 약물의 경구투여용 나노입자 조성물 및 그의제조방법 |
US7846201B2 (en) * | 2004-02-20 | 2010-12-07 | The Children's Hospital Of Philadelphia | Magnetically-driven biodegradable gene delivery nanoparticles formulated with surface-attached polycationic complex |
US8562505B2 (en) * | 2004-02-20 | 2013-10-22 | The Children's Hospital Of Philadelphia | Uniform field magnetization and targeting of therapeutic formulations |
US9028829B2 (en) * | 2004-02-20 | 2015-05-12 | The Children's Hospital Of Philadelphia | Uniform field magnetization and targeting of therapeutic formulations |
US20060003956A1 (en) * | 2004-03-03 | 2006-01-05 | Casadome David O | Materials and methods for the derepression of the E-cadherin promoter |
WO2005087221A1 (en) * | 2004-03-15 | 2005-09-22 | Christine Allen | Biodegradable biocompatible implant and method of manufacturing same |
CN1311867C (zh) * | 2004-09-27 | 2007-04-25 | 侯新朴 | 一种用于鼻腔给药的神经生长因子制剂 |
ES2259914B1 (es) * | 2005-03-14 | 2007-06-16 | Advanced In Vitro Cell Technologies, S.L. | Nanoparticulas de quitosano y polietilenglicol como sistema de administracion de moleculas biologicamente activas. |
ATE515260T1 (de) * | 2006-03-13 | 2011-07-15 | Advanced In Vitro Cell Technologies S L | Stabile nanokapselsysteme für die verabreichung von wirkstoffen |
US7977103B2 (en) | 2006-04-20 | 2011-07-12 | Kimberly-Clark Worldwide, Inc. | Method for detecting the onset of ovulation |
US20080153789A1 (en) * | 2006-12-26 | 2008-06-26 | Femmepharma Holding Company, Inc. | Topical administration of danazol |
WO2008135828A2 (en) | 2007-05-03 | 2008-11-13 | Pfizer Products Inc. | Nanoparticles comprising a drug, ethylcellulose, and a bile salt |
WO2008135855A2 (en) | 2007-05-03 | 2008-11-13 | Pfizer Products Inc. | Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a nonionizable polymer |
EP2162120B1 (de) | 2007-06-04 | 2016-05-04 | Bend Research, Inc | Nanopartikel mit nicht ionisierbarem zellulosepolymer und amphipilem nicht ionisierbarem blockcopolymer |
US9545384B2 (en) | 2007-06-04 | 2017-01-17 | Bend Research, Inc. | Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glocol succinate |
EP2231169B1 (de) | 2007-12-06 | 2016-05-04 | Bend Research, Inc. | Pharmazeutische zusammensetzungen mit nanopartikeln und resuspensionsmaterial |
US9233078B2 (en) | 2007-12-06 | 2016-01-12 | Bend Research, Inc. | Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer |
IL188647A0 (en) * | 2008-01-08 | 2008-11-03 | Orina Gribova | Adaptable structured drug and supplements administration system (for oral and/or transdermal applications) |
US8778400B2 (en) * | 2008-04-21 | 2014-07-15 | University Of South Australia | Nanoparticle-stabilized capsule formulation for treatment of inflammation |
US9207242B2 (en) | 2008-10-09 | 2015-12-08 | The University Of Hong Kong | Cadherin-17 as diagnostic marker and therapeutic target for liver cancer |
EP2266546A1 (de) | 2009-06-08 | 2010-12-29 | Advancell Advanced in Vitro Cell Technologies,S.A. | Verfahren zur Herstellung kolloidaler Systeme zur Abgabe von Wirkstoffen |
US20110003000A1 (en) * | 2009-07-06 | 2011-01-06 | Femmepharma Holding Company, Inc. | Transvaginal Delivery of Drugs |
CA2767342C (en) | 2009-07-09 | 2018-05-01 | Oshadi Drug Administration Ltd. | Matrix carrier compositions, methods and uses |
EP2361509A1 (de) | 2010-02-15 | 2011-08-31 | Nestec S.A. | Flüssigkeitsgefüllte Protein-Phosphatidsäurenkapseldispersionen |
EP2364600A1 (de) | 2010-02-18 | 2011-09-14 | Nestec S.A. | Flüssigkeitsgefüllte chitosan-anionische fettlösliche Kapseldispersionen |
BRPI1002601E2 (pt) * | 2010-06-01 | 2020-06-30 | Embrapa Pesquisa Agropecuaria | composição nanoestruturada de uso veterinário para administração de fármacos |
US9326980B2 (en) * | 2013-07-21 | 2016-05-03 | Kimia Zist Parsian (Kzp) | Method and system for synthesizing nanocarrier based long acting drug delivery system for buprenorphine |
US9351932B2 (en) * | 2014-07-21 | 2016-05-31 | Kimia Zist Parsian (Kzp) | Method and system for synthesizing nanocarrier based long acting drug delivery system for methadone |
PL229276B1 (pl) | 2015-07-17 | 2018-06-29 | Univ Jagiellonski | Nanokapsuła do przenoszenia związku lipofilowego i sposób jej wytwarzania |
GB201522186D0 (en) | 2015-12-16 | 2016-01-27 | Singapore Health Services Pte Ltd And Nat University Of Singapore The | Treatment of fibrosis |
US20200129575A1 (en) | 2017-02-09 | 2020-04-30 | Universidade De Santiago De Compostela | Purified pollen particles and use thereof for administering nanosystems |
US11883401B2 (en) | 2019-01-08 | 2024-01-30 | Duke University | Compositions for the treatment of pathogenic- and/or chemical-induced lung injury and for the treatment of cancer and methods of using same |
CN113677706A (zh) | 2019-01-21 | 2021-11-19 | 新加坡保健服务私人有限公司 | 肝毒性的治疗 |
GB201902419D0 (en) | 2019-02-22 | 2019-04-10 | Singapore Health Serv Pte Ltd | Treatment of kidney injury |
CA3146344A1 (en) | 2019-05-03 | 2020-11-12 | Singapore Health Services Pte. Ltd. | Treatment and prevention of metabolic diseases |
GB201906291D0 (en) | 2019-05-03 | 2019-06-19 | Singapore Health Serv Pte Ltd | Treatment and prevention of metabolic diseases |
GB202009292D0 (en) | 2020-06-18 | 2020-08-05 | Singapore Health Serv Pte Ltd | Treatment and prevention of disease caused by type IV collagen dysfunction |
GB202017244D0 (en) | 2020-10-30 | 2020-12-16 | Nat Univ Singapore | Methods to extend health-span and treat age-related diseases |
EP4376948A1 (de) | 2021-07-26 | 2024-06-05 | Boehringer Ingelheim International GmbH | Behandlung und prävention von alkoholischer lebererkrankung |
WO2023111196A1 (en) | 2021-12-16 | 2023-06-22 | Singapore Health Services Pte. Ltd. | Treatment and prevention of glomerular disease |
GB202212077D0 (en) | 2022-08-18 | 2022-10-05 | Tribune Therapeutics Ab | Agents that inhibit ccn ligand-induced signalling for treating disease |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1243390B (it) * | 1990-11-22 | 1994-06-10 | Vectorpharma Int | Composizioni farmaceutiche in forma di particelle atte al rilascio controllato di sostanze farmacologicamente attive e procedimento per la loro preparazione. |
IL101241A (en) * | 1992-03-16 | 1997-11-20 | Yissum Res Dev Co | Pharmaceutical or cosmetic composition comprising stabilized oil-in-water type emulsion as carrier |
-
1995
- 1995-05-26 ES ES09501035A patent/ES2093562B1/es not_active Expired - Fee Related
-
1996
- 1996-05-24 WO PCT/ES1996/000116 patent/WO1996037232A1/es active IP Right Grant
- 1996-05-24 PT PT96914215T patent/PT771566E/pt unknown
- 1996-05-24 DE DE69634927T patent/DE69634927T2/de not_active Expired - Lifetime
- 1996-05-24 DK DK96914215T patent/DK0771566T3/da active
- 1996-05-24 US US08/776,507 patent/US5843509A/en not_active Expired - Lifetime
- 1996-05-24 EP EP96914215A patent/EP0771566B1/de not_active Expired - Lifetime
- 1996-05-24 CA CA002195881A patent/CA2195881C/en not_active Expired - Fee Related
- 1996-05-24 AT AT96914215T patent/ATE330636T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE69634927T2 (de) | 2008-05-15 |
ATE330636T1 (de) | 2006-07-15 |
ES2093562A1 (es) | 1996-12-16 |
CA2195881A1 (en) | 1996-11-28 |
ES2093562B1 (es) | 1997-07-01 |
US5843509A (en) | 1998-12-01 |
DE69634927D1 (de) | 2005-08-18 |
EP0771566A1 (de) | 1997-05-07 |
EP0771566B1 (de) | 2006-06-21 |
CA2195881C (en) | 2006-09-12 |
WO1996037232A1 (es) | 1996-11-28 |
PT771566E (pt) | 2006-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0771566T3 (da) | Stabilisering af kolloidale systemer ved dannelsen af ioniske lipidpolysaccharidkomplekser | |
Zimmer et al. | Evaluation of pilocarpine-loaded albumin particles as controlled drug delivery systems for the eye. II. Co-administration with bioadhesive and viscous polymers | |
US5989535A (en) | Polymeric bioadhesive emulsions and suspensions and methods of treatment | |
JP3323499B2 (ja) | 正電荷粒子の油/水エマルジョン | |
Badawi et al. | Chitosan based nanocarriers for indomethacin ocular delivery | |
Gurny et al. | Ocular therapy with nanoparticulate systems for controlled drug delivery | |
AU692460B2 (en) | Bioadhesive emulsion preparations for enhanced drug delivery | |
EP0995435B1 (de) | Wässrige suspensionspräparationen mit exzellenter redispersibilität | |
US5993831A (en) | Composition providing a lasting cosmetic and/or pharmaceutical treatment of the upper epidermal layers by topical application on the skin | |
Davies et al. | Evaluation of mucoadhesive polymers in ocular drug delivery. II. Polymer-coated vesicles | |
JP2969584B2 (ja) | 眼の治療用組成物 | |
AU673023B2 (en) | Cosmetic delivery system for salicylic acid and process for preparation of the same | |
US5660853A (en) | Process for manufacturing a cosmetics composition for application to hair, composition obtained by this process and process for cosmetic treatment using the said composition | |
JP3624418B2 (ja) | リポソーム点眼液 | |
EP0609963B1 (de) | Topische Zubereitungen enthaltend Benzimidazol-Derivate und Benzotriazol-Derivate | |
Diepold et al. | Distribution of poly-hexyl-2-cyano-[3-14C] acrylate nanoparticles in healthy and chronically inflamed rabbit eyes | |
CA2233501C (en) | Application of nanoparticles based on hydrophilic polymers as pharmaceutical forms | |
WO2000009096B1 (en) | Injectable formulations of nanoparticulate naproxen | |
WO1993000076A1 (en) | Carrier systems for drugs | |
EP0463065B1 (de) | Antischwitzzusatzmittel und verfahren zur herstellung | |
WO1998011874A1 (en) | Pharmaceutical composition forming a gel | |
JPS60204708A (ja) | 化粧料用保湿剤 | |
WO1992003123A1 (en) | Liposome alternative bilayer formulations | |
JPH08510731A (ja) | 治療使用のためのその場で生成するゲル | |
Bhadra et al. | Multicomposite ultrathin capsules for sustained ocular delivery of ciprofloxacin hydrochloride |